|
|
Thorough QT (TQT) Studies
Technical Know How – RPL’s ECG Core Lab
Richmond Pharmacology’s Core ECG Laboratory was established in 2004 to provide centralized digital and manual ECG data analysis for Richmond Pharmacology’s in house TQT trials, in addition to ECG reading, analysis and reporting for clinical trials conducted at other centres...
TQT Studies - ECG Core Lab |
|
Digital ECG Analysis and Cardiologist Experience
Thorough QT/QTc (TQT) studies are today an integral component in the development of new chemical entities (NCE) and on going drug development programmes. These studies are now so significant that they can mean the difference between the continuation and an abrupt halt of a drug development program.
Digital ECG Analysis and Cardiologist Experience |
Cardio Analysis Services
Richmond Pharmacology’s Core ECG Laboratory has worked with numerous clinical units worldwide and participated in 200 clinical trials sponsored by pharmaceutical companies...
Cardio Analysis Services |
|
MEET THE EXPERTS
Richmond Pharmacology's people have extensive knowledge and expertise.

A DECADE OF EXCELLENCE
Proud to be celebrating
10 years of clinical
excellence...
Learn More

WE RISE TO THE CHALLENGE
We know we can help your
business. We always rise
to the challenge…
Challenge Us
|
Thorough QT (TQT) Richmond Pharmacology is one of the leading providers of TQT studies. All TQT studies performed at Richmond
Pharmacology are in collaboration with Professor Camm, Head of Cardiac and Vascular Sciences, St George's University of London, a world renowned opinion leader in cardiological analysis, providing a one stop solution unique in the field of contract research.
Richmond Pharmacology provide technical expertise for all your QTc study needs from study design, clinical conduct, ECG data management, QTc measurement and analysis, through to the final study report.
There are three essential components to any clinical study assessing the effects on the QT interval:
1) The clinical recording of ECGs
2) The measurement and verification of measurements
3) The statistical analysis of potential effects
Of these three it is essential that the clinical recording of the ECG’s are performed to the highest standard as this provides the foundation for successful completion of the other two components.
Richmond Pharmacology’s innovative approach to the conduct of TQT studies has reduced the variability rates allowing one to reduce the overall costs. In-house expertise and past experience makes Richmond Pharmacology the ideal partner for performing definitive TQT studies, all under one roof.